{
    "root": "348dbfd5-d64c-75f2-e063-6394a90ab0a6",
    "code": "34391-3",
    "codeSystem": "2.16.840.1.113883.6.1",
    "displayName": "HUMAN PRESCRIPTION DRUG LABEL",
    "name": "ALENDRONATE SODIUM",
    "value": "20250507",
    "ingredients": [
        {
            "name": "MANNITOL",
            "code": "3OWL53L36A"
        },
        {
            "name": "CELLULOSE, MICROCRYSTALLINE",
            "code": "OP1R32D61U"
        },
        {
            "name": "SODIUM STARCH GLYCOLATE TYPE A POTATO",
            "code": "5856J3G2A2"
        },
        {
            "name": "STARCH, CORN",
            "code": "O8232NY3SJ"
        },
        {
            "name": "MAGNESIUM STEARATE",
            "code": "70097M6I30"
        },
        {
            "name": "ALENDRONATE SODIUM",
            "code": "2UY4M2U3RA"
        }
    ],
    "indications": "alendronate sodium bisphosphonate indicated : treatment prevention osteoporosis postmenopausal women ( 1.1 , 1.2 ) treatment increase bone mass men osteoporosis ( 1.3 ) treatment glucocorticoid-induced osteoporosis ( 1.4 ) treatment paget 's disease bone ( 1.5 ) limitations : optimal duration determined . patients low- risk fracture , consider discontinuation 3 5 years . ( 1.6 )",
    "contraindications": "treatment osteoporosis postmenopausal women men : 10 mg daily 70 mg ( tablet ) weekly . ( 2.1 , 2.3 ) prevention osteoporosis postmenopausal women : 5 mg daily 35 mg weekly . ( 2.2 ) glucocorticoid-induced osteoporosis : 5 mg daily ; 10 mg daily postmenopausal women receiving estrogen . ( 2.4 ) paget 's disease : 40 mg daily six months . ( 2.5 ) instruct patients : ( 2.6 ) swallow tablets whole 6-8 ounces plain water least 30 minutes first food , drink , medication day . lie least 30 minutes taking alendronate sodium tablets food .",
    "warningsAndPrecautions": "35 mg tablets alendronate sodium tablets usp , 35 mg white , capsule shaped , biconvex tablets debossed 'c223 ' one side plain side . ndc : 70518-1192-00 ndc : 70518-1192-01 packaging : 4 1 blister pack packaging : 3 1 carton , 4 1 blister pack storage store 20°c 25°c ( 68°f to77°f ) ; excursions permitted 15°c 30°c ( 59°f 86°f ) [ usp controlled room temperature ] . dispense tight , light-resistant container . repackaged distributed : remedy repack , inc. 625 kolter dr. suite # 4 indiana , pa 1-724-465-8762",
    "adverseReactions": "abnormalities esophagus delay esophageal emptying stricture achalasia [ ( 4 , 5.1 ) ] inability stand/sit upright least 30 minutes ( 2.6 , 4 , 5.1 ) hypocalcemia ( 4 , 5.2 ) hypersensitivity component product ( 4 , 6.2 )",
    "indications_original": "Alendronate sodium is a bisphosphonate indicated for: Treatment and prevention of osteoporosis in postmenopausal women ( 1.1 , 1.2 ) Treatment to increase bone mass in men with osteoporosis ( 1.3 ) Treatment of glucocorticoid-induced osteoporosis ( 1.4 ) Treatment of Paget's disease of bone ( 1.5 ) Limitations of use: Optimal duration of use has not been determined. For patients at low- risk for fracture, consider drug discontinuation after 3 to 5 years of use. (1.6)",
    "contraindications_original": "Treatment of osteoporosis in postmenopausal women and in men: 10 mg daily or 70 mg (tablet) once weekly. ( 2.1 , 2.3 ) Prevention of osteoporosis in postmenopausal women: 5 mg daily or 35 mg once weekly. ( 2.2 ) Glucocorticoid-induced osteoporosis: 5 mg daily; or 10 mg daily in postmenopausal women not receiving estrogen. ( 2.4 ) Paget's disease: 40 mg daily for six months. ( 2.5 ) Instruct patients to: ( 2.6 ) o   Swallow tablets whole with 6-8 ounces plain water at least 30 minutes before the first food, drink, or medication of the day. o   Not lie down for at least 30 minutes after taking alendronate sodium tablets and until after food.",
    "warningsAndPrecautions_original": "35 mg Tablets\n                  Alendronate Sodium Tablets USP, 35 mg are white, capsule shaped, biconvex tablets debossed with 'C223' on one side and plain on the other side.\n                  NDC: 70518-1192-00\n                  NDC: 70518-1192-01\n                  PACKAGING: 4 in 1 BLISTER PACK\n                  PACKAGING: 3 in 1 CARTON, 4 in 1 BLISTER PACK\n                  \n                  Storage\n                  Store at 20°C to 25°C (68°F to77°F); excursions permitted to 15°C to 30°C (59°F to 86°F) [see USP Controlled Room Temperature].\n                  Dispense in a tight, light-resistant container.\n                  \n                  Repackaged and Distributed By:\n                  Remedy Repack, Inc.\n                  625 Kolter Dr. Suite #4 Indiana, PA 1-724-465-8762",
    "adverseReactions_original": "Abnormalities of the esophagus which delay esophageal emptying such as stricture or achalasia [see Warnings and Precautions ( 4 , 5.1 )] Inability to stand/sit upright for at least 30 minutes ( 2.6 , 4 , 5.1 ) Hypocalcemia ( 4 , 5.2 ) Hypersensitivity to any component of this product ( 4 , 6.2 )"
}